Akèy › Neurofibrosarkòm
Etid klinik pou Neurofibrosarkòm ap rekrite nan Etazini
14 etid pou Neurofibrosarkòm ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY6 etid
- Washington, DC6 etid
- St. Louis, MO4 etid
- Boston, MA4 etid
- Houston, TX3 etid
- Cincinnati, OH3 etid
- Chicago, IL3 etid
- Mountain View, CA3 etid
- Queens, NY3 etid
- Edison, NJ3 etid
Pa eta
- Illinois3 etid
- Kalifòni3 etid
- Maryland4 etid
- Massachusetts5 etid
- Missouri4 etid
- New Jersey3 etid
- New York6 etid
- Ohio4 etid
- Tennessee4 etid
- Texas5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 12 a 120 · Tout sèks · Mizajou Sep 23, 2026 · NCT04222413DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
Ap rekriteEtid obsèvasyon
Laj 1 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07298083Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05245500Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
Ap rekriteEtid obsèvasyon
Laj 3 a 120 · Tout sèks · Mizajou Sep 2, 2026 · NCT06222203Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Ap rekriteFaz 2
Laj 18 a 99 · Tout sèks · Mizajou Aug 24, 2026 · NCT05253131Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07549022SPEARHEAD-3 Pediatric Study
Ap rekriteFaz 1/2
Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Ap rekriteFaz 1/2
Jiska laj 30 · Tout sèks · Mizajou Aug 3, 2026 · NCT06239272Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06735820B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Ap rekriteFaz 1
Jiska laj 21 · Tout sèks · Mizajou May 19, 2026 · NCT04897321A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Ap rekriteFaz 2
12 Months · Tout sèks · Mizajou May 6, 2026 · NCT05985161Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Mar 9, 2026 · NCT03141021A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
Ap rekriteFaz 2
Laj 16 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT04872543Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.